Personal information

Countries

Türkiye

Activities

Collapse all

Employment (1)

Marmara Universitesi Tip Fakultesi: Istanbul, TR

2020-05-12 to present | resident physician (infectious diseases and clinical microbiology department)
Employment
Source: Self-asserted source
Gökçe Melis Çolak

Works (12)

Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Infection
2024-06 | Journal article
DOI: 10.1007/s15010-024-02240-x
Part of ISSN: 0300-8126
Part of ISSN: 1439-0973
Contributors: Tobias; Jon Salmanton-García; Francesco Marchesi; Shaimaa El-Ashwah; Marcio Nucci; Caroline Besson; Federico Itri; Ozren Jaksic; Natasa; Barbora Weinbergerova et al.
Source: Self-asserted source
Gökçe Melis Çolak

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

Infection
2024-06 | Journal article
DOI: 10.1007/s15010-023-02169-7
Part of ISSN: 0300-8126
Part of ISSN: 1439-0973
Contributors: Tobias; Jon Salmanton-García; Francesco Marchesi; Shaimaa El-Ashwah; Marcio Nucci; Caroline Besson; Federico Itri; Ozren Jaksic; Natasa; Barbora Weinbergerova et al.
Source: Self-asserted source
Gökçe Melis Çolak

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

eClinicalMedicine
2024-05 | Journal article
DOI: 10.1016/j.eclinm.2024.102553
Part of ISSN: 2589-5370
Contributors: Jon Salmanton-García; Francesco Marchesi; Francesca Farina; Barbora Weinbergerová; Federico Itri; Julio Dávila-Valls; Sonia Martín-Pérez; Andreas Glenthøj; Ditte Stampe Hersby; Maria Gomes Da Silva et al.
Source: Self-asserted source
Gökçe Melis Çolak

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry

Haematologica
2024-04-04 | Journal article
DOI: 10.3324/haematol.2023.284678
Part of ISSN: 1592-8721
Part of ISSN: 0390-6078
Contributors: Tommaso Francesco Aiello; Jon Salmanton-Garcia; Francesco Marchesi; Barbora Weinbergerova; Andreas Glenthoj; Jens Van Praet; Francesca Farina; Julio Davila-Valls; Sonia Martin-Perez; Shaimaa El-Ashwah et al.
Source: Self-asserted source
Gökçe Melis Çolak

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry

Hematological Oncology
2024-01 | Journal article
DOI: 10.1002/hon.3240
Part of ISSN: 0278-0232
Part of ISSN: 1099-1069
Contributors: Pellegrino Musto; Jon Salmanton-García; Nicola Sgherza; Rui Bergantim; Francesca Farina; Andreas Glenthøj; Guldane Cengiz Seval; Barbora Weinbergerova; Valentina Bonuomo; Yavuz M. Bilgin et al.
Source: Self-asserted source
Gökçe Melis Çolak

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

International Journal of Infectious Diseases
2023-12 | Journal article
DOI: 10.1016/j.ijid.2023.10.013
Part of ISSN: 1201-9712
Contributors: Giuseppe Rossi; Jon Salmanton-García; Chiara Cattaneo; Francesco Marchesi; Julio Dávila-Valls; Sonia Martín-Pérez; Federico Itri; Alberto Lopez-Garcia; Andreas Glenthøj; Maria Gomes da Silva et al.
Source: Self-asserted source
Gökçe Melis Çolak

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

International Journal of Antimicrobial Agents
2023-10 | Journal article | Author
DOI: 10.1016/j.ijantimicag.2023.106952
Part of ISSN: 0924-8579
Contributors: Jon Salmanton-García; Francesco Marchesi; Philipp Koehler; Barbora Weinbergerová; Natasa Čolović; Iker Falces-Romero; Caterina Buquicchio; Francesca Farina; Jens Tomas Van Praet; Monika M. Biernat et al.
Source: Self-asserted source
Gökçe Melis Çolak

P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT

HemaSphere
2023-08-08 | Journal article
DOI: 10.1097/01.hs9.0000972964.65137.d1
Part of ISSN: 2572-9241
Contributors: Jon Salmanton-García; Francesco Marchesi; Andreas Glenthøj; Yavuz M. Bilgin; Jens VAN Praet; Julio Dávila-Valls; Sonia Martín-Pérez; Jorge Labrador; Jaap Van Doesum; Iker Falces-Romero et al.
Source: Self-asserted source
Gökçe Melis Çolak

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

eClinicalMedicine
2023-04 | Journal article
DOI: 10.1016/j.eclinm.2023.101939
Part of ISSN: 2589-5370
Contributors: Jon Salmanton-García; Francesco Marchesi; Maria Gomes da Silva; Francesca Farina; Julio Dávila-Valls; Yavuz; Andreas Glenthøj; Iker Falces-Romero; Jaap Van Doesum; Jorge Labrador et al.
Source: Self-asserted source
Gökçe Melis Çolak

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

HemaSphere
2022-11 | Journal article
DOI: 10.1097/hs9.0000000000000789
Part of ISSN: 2572-9241
Contributors: Jon Salmanton-García; Francesco Marchesi; Andreas Glenthøj; Yavuz M. Bilgin; Jens van Praet; Julio Dávila-Valls; Sonia Martín-Pérez; Jorge Labrador; Jaap van Doesum; Iker Falces-Romero et al.
Source: Self-asserted source
Gökçe Melis Çolak

Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

Cancers
2022-11-10 | Journal article
DOI: 10.3390/cancers14225530
Part of ISSN: 2072-6694
Contributors: Chiara Cattaneo; Jon Salmanton-García; Francesco Marchesi; Shaimaa El-Ashwah; Federico Itri; Barbora Weinbergerová; Maria Gomes da Silva; Michelina Dargenio; Julio Davila Valls; Sonia Martín-Pérez et al.
Source: Self-asserted source
Gökçe Melis Çolak

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Journal of Hematology & Oncology
2021-10-14 | Journal article
Source: Self-asserted source
Gökçe Melis Çolak
How many people are using ORCID?